As cofounder and CEO of GenFleet, Dr. Jiong Lan is responsible for overall supervision and management of the business operation of the company. He boasts over two decades of diverse experience and his expertise spans across medicinal chemistry, drug discovery, and development strategy. He participated in the development of multiple marketed products as the inventor; besides, he directed the R&D of over 20 drug candidates and holds over 140 authorized patents.
Dr. Lan earned his Ph.D. from Lanzhou University in China and completed post-doctoral research at the University of Rochester. Following his graduation in the United States, he embarked on his overseas career as a senior researcher and project leader at Traid Therapeutic, Neurogen Corp., and Novartis. He later joined Hengrui Therapeutics in China, serving as the program director for small-molecule drug development. Prior to joining GenFleet, he held the position of general manager at Shanghai Haiyan Pharmaceutical Technology, where he was responsible for shaping the R&D system for innovative therapies and overseeing the company's overall operations.
